SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000728889-03-000140
Filing Date
2003-02-14
Accepted
2003-02-14 15:08:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 BODY neurogenbody.htm SC 13G/A 18160
  Complete submission text file 0000728889-03-000140.txt   20266
Mailing Address 498 SEVENTH AVENUE 14TH FLOOR NEW YORK NY 10018
Business Address 498 SEVENTH AVENUE 14TH FLOOR NEW YORK NY 10018 212-323-0200
OPPENHEIMER FUNDS INC (Filed by) CIK: 0000728889 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
SIC: 0000

Mailing Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405 2034888201
NEUROGEN CORP (Subject) CIK: 0000849043 (see all company filings)

IRS No.: 222845714 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-41776 | Film No.: 03566890
SIC: 2834 Pharmaceutical Preparations